Crossmark

Sustained Release of Antifibrotic Nintedanib from Polymer Microparticles Reduces Dosing Frequency While Reducing Inflammation in Murine Idiopathic Pulmonary Fibrosis

Crossref DOI link: https://doi.org/10.1007/s10439-025-03729-8

Published Online: 2025-04-10

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Opolot, Emmanuel Einyat

Goshevski, Filip

Chaudhary, Rahul

Kilgore, Jessica A.

Williams, Noelle S.

von Recum, Horst A.

Desai, Amar B. https://orcid.org/0000-0001-8649-6630
Funding

Funding for this research was provided by:

Clinical and Translational Science Collaborative of Northern Ohio (UM1TR004528)

NCI (P30CA043703)
License Information

Text and Data Mining valid from 2025-04-10

Version of Record valid from 2025-04-10
More Information

Article History

Received: 15 November 2024

Accepted: 29 March 2025

First Online: 10 April 2025

Declarations

:

: The authors declare that this research was conducted without any commercial or financial affiliations that could be perceived as a potential conflict of interest.

Document is current

Any future updates will be listed below